Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see Warnings and Precautions (5.7) and Drug Interactions (7.1)]
ab51067, Abcam, Cambridge, UK), anti-p-c-Met (Cat No
Through trustworthy, data-backed recommendations delivered in as little as two weeks, Thrivable brings the patient perspective closer to healthcare decision-making, working alongside existing tools and research approaches, to help teams move beyond assumptions and make clearer, more confident decisions grounded in the lived patient experience
Bundle 2 Advanced Glow Set
Clinical evidence for this concern remains limited at therapeutic doses
J Clin Endocrinol Metab 2012;97:121131